Haematoxylin and eosin platform change.
We are changing our platform for the haematoxylin and eosin stain used for all routine histopathology cases to the Roche HE600 platform from Monday 4th September 2017. This is to allow us to improve the workflow and traceability of reagents used.
The existing platform will remain in use as contingency and for macro slide staining.
During slide review at MDT meetings you may notice a difference in the tone of the staining.
This new platform will be assessed by UKAS against ISO 15189 standards at our next annual inspection in October.
For further information about this change please contact the department on 0121 424 3188 and ask to speak to a senior member of staff.